Iraqi Journal of Hematology

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 11  |  Issue : 2  |  Page : 118--124

A role of interim positron emission tomography/computed tomography scan in the management of Hodgkin lymphoma: A single-center study in a developing country


Saya Azeez1, Ahmed Khudair Yassin2, Nawsherwan S Mohammad3, Kawa M Hassan2, Zeki A Mohamed4, Ranan Kardagh Polus5, Hawar Gh. Khudhur1 
1 Trainee at Kurdistan Higher Council of Medical Specialties/ Clinical Hematology, Nanakali Hospital – Erbil - Kurdistan Region, Iraq
2 Department of Medicine, College of Medicine, Hawler Medical University, Erbil, Kurdistan Region, Iraq
3 Laboratory Hematopathologist- Nanakali Hospital-Erbil-Kurdistan Region, Duhok, Kurdistan Region, Iraq
4 Department of Medicine, College of Medicine, University of Duhok, Duhok, Kurdistan Region, Iraq
5 Kurdistan Higher Council of Medical Specialties/ Head of Pathology Council, Erbil, Kurdistan Region, Iraq

Correspondence Address:
Dr. Saya Azeez
Nanakali Hospital, Erbil, Kurdistan Region
Iraq

BACKGROUND: The Hodgkin lymphoma (HL) showed a good prognosis in Erbil city. However, a number of deaths were reported. The monitoring and treatment strategies of HL had improved in the last decade. AIMS: The aims of this study were to evaluate the prognostic value of interim positron emission tomography/computed tomography (PET/CT) scan in HL patients and predicting the survival outcome in addition to effect on progression-free survival (PFS) of HL patients. PATIENTS AND METHODS: A retrospective cross-sectional study was conducted in Nanakali Hospital in Erbil city, Kurdistan region, Iraq, through reviewing data of patients with HL from January 1, 2014, to December 31, 2019, on a sample of 75 HL patients. The diagnosis of HL was accomplished by the physician regarding lymph node biopsy by the World Health Organization criteria. The PET/CT scan was done after two treatment cycles. PET/CT of HL patients was done in a private center in Erbil city (Media Diagnostic Center). RESULTS: The mean overall survival duration of HL patients was 5.39 years with an overall survival rate of 92%, and the mean PFS duration of HL patients was 5.04 years with PFS rate of 76%. The mean overall survival of HL patients with positive interim PET/CT (4 years and rate 75%) was lower than the mean overall survival of HL patients with negative interim PET/CT (7.2 years and rate of 95.2%) with a significant difference (P < 0.001). CONCLUSIONS: The interim PET/CT scan is useful in prognosis of patients with HL and predicting overall survival and mortality.


How to cite this article:
Azeez S, Yassin AK, Mohammad NS, Hassan KM, Mohamed ZA, Polus RK, Khudhur HG. A role of interim positron emission tomography/computed tomography scan in the management of Hodgkin lymphoma: A single-center study in a developing country.Iraqi J Hematol 2022;11:118-124


How to cite this URL:
Azeez S, Yassin AK, Mohammad NS, Hassan KM, Mohamed ZA, Polus RK, Khudhur HG. A role of interim positron emission tomography/computed tomography scan in the management of Hodgkin lymphoma: A single-center study in a developing country. Iraqi J Hematol [serial online] 2022 [cited 2023 Jan 27 ];11:118-124
Available from: https://www.ijhonline.org/article.asp?issn=2072-8069;year=2022;volume=11;issue=2;spage=118;epage=124;aulast=Azeez;type=0